Obesity By The Numbers
Executive Summary
Obesity is one of the most prevalent diseases in the US, according to CDC, which estimates that about one-third of Americans, or 76 million adults, are obese. Obesity leads to other chronic conditions like diabetes, heart disease and some cancers. Yet, patients and physicians have been slow to turn to drugs for treatment.
You may also be interested in...
Obesity Companies Prolong The Inevitable As Cash Runs Out
Arena and Vivus both announce efforts to conserve cash and they struggle with virtually nonexistent sales of their obesity drugs. Neither company has laid out plans for next steps.
IPO Update: Patheon Public Once Again, Audentes To Move Into The Clinic
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.
Zafgen Drops Beloranib, But Its New Focus Raises Doubts
The biotech is shifting gears after clinical hold on its lead drug was unlikely to be lifted, but the early-stage candidate that it's placing its hopes on is raising red flags for analysts and investors.